Prelude Capital Management, LLC Electro Core, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.85 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$0.8 - $2.33 $1,530 - $4,457
-1,913 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.75 - $1.29 $1,434 - $2,467
1,913 New
1,913 $2,000

Others Institutions Holding ECOR

# of Institutions
3
Shares Held
143K
Call Options Held
0
Put Options Held
0
View Full List

About electroCore, Inc.

ECOR Quotes by TradingView
  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email